# FDA Inspection 1014057 - Albert Max, Inc. - May 25, 2017

Source: https://www.keypedia.com/records/fda_inspections/albert-max-inc/0dffa158-6426-43a7-9712-e9cec50a3729
Source feed: FDA_Inspections

> FDA Inspection 1014057 for Albert Max, Inc. on May 25, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014057
- Company Name: Albert Max, Inc.
- Inspection Date: 2017-05-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1142624 - 2021-04-15](https://www.keypedia.com/records/fda_inspections/albert-max-inc/4df314df-290d-40e5-9e59-564124fd83fa)
- [FDA Inspection 989423 - 2016-09-16](https://www.keypedia.com/records/fda_inspections/albert-max-inc/0d6d9a24-26c5-4814-9ad6-21bf94fc0182)
- [FDA Inspection 833396 - 2013-05-28](https://www.keypedia.com/records/fda_inspections/albert-max-inc/59cbe84e-fd7d-430d-a3e8-2cccf44628b6)
- [FDA Inspection 584290 - 2009-05-19](https://www.keypedia.com/records/fda_inspections/albert-max-inc/26d244ea-3ce9-4d28-b812-4b0fa4577004)

Company: https://www.keypedia.com/companies/albert-max-inc/250f0fb9-c382-4c19-9796-00bb80079b0a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c